Hepion Pharmaceuticals (HEPA)
(Delayed Data from NSDQ)
$1.37 USD
+0.08 (6.20%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $1.40 +0.03 (2.19%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth A Momentum C VGM
Cash flow Statements
Fiscal Year End for Hepion Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -48.93 | -42.20 | -32.72 | -20.35 | -6.72 |
Depreciation/Amortization & Depletion | 3.26 | 1.95 | 0.09 | 0.03 | 0.51 |
Net Change from Assets/Liabilities | 2.97 | 3.15 | -5.57 | 1.63 | -0.75 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 1.81 | 2.14 | 6.98 | 2.53 | -0.61 |
Net Cash From Operating Activities | -40.89 | -34.96 | -31.22 | -16.17 | -7.57 |
Property & Equipment | -0.01 | -0.01 | -0.13 | -0.09 | -0.05 |
Acquisition/ Disposition of Subsidiaries | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | -0.01 | -0.01 | -0.13 | -0.09 | -0.05 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 4.49 | -3.14 | 82.15 | 42.88 | 19.83 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | -0.18 | 0.00 | -1.12 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | -2.00 | 0.00 | 0.18 | 0.00 |
Net Cash from Financing Activities | 4.49 | -5.14 | 81.98 | 43.05 | 18.71 |
Effect of Exchange Rate Changes | 0.01 | -0.05 | 0.00 | 0.00 | 0.00 |
Net Change In Cash & Equivalents | -36.40 | -40.16 | 50.62 | 26.80 | 11.09 |
Cash at Beginning of Period | 51.19 | 91.35 | 40.73 | 13.92 | 2.83 |
Cash at End of Period | 14.79 | 51.19 | 91.35 | 40.73 | 13.92 |
Diluted Net EPS | -12.32 | -11.80 | -9.40 | -42.00 | -119.00 |
Fiscal Year End for Hepion Pharmaceuticals, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | NA | -48.93 | -37.87 | -27.34 | -13.26 |
Depreciation/Amortization & Depletion | NA | 3.26 | 0.05 | 0.04 | 0.02 |
Net Change from Assets/Liabilities | NA | 2.97 | 4.91 | 5.82 | 3.05 |
Net Cash from Discontinued Operations | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | NA | 1.81 | 1.01 | 0.83 | 1.98 |
Net Cash From Operating Activities | NA | -40.89 | -31.89 | -20.65 | -8.21 |
Property & Equipment | NA | -0.01 | -0.01 | -0.02 | 0.00 |
Acquisition/ Disposition of Subsidiaries | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Investments | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Investing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Investing Activities | NA | -0.01 | -0.01 | -0.02 | 0.00 |
Uses of Funds
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | 3/31/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | NA | 4.49 | 0.00 | 0.00 | 0.00 |
Issuance (Repayment) of Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | NA | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | NA | 4.49 | 0.00 | 0.00 | 0.00 |
Effect of Exchange Rate Changes | NA | 0.01 | 0.00 | 0.00 | 0.02 |
Net Change In Cash & Equivalents | NA | -36.40 | -31.91 | -20.67 | -8.20 |
Cash at Beginning of Period | NA | 51.19 | 51.19 | 51.19 | 51.19 |
Cash at End of Period | NA | 14.79 | 19.28 | 30.52 | 42.99 |
Diluted Net EPS | NA | -2.42 | -2.74 | -3.68 | -3.48 |